Andhi Bahtiar, Adis Imam Munandar


The use of telemedicine is one of the strategic policies of the Indonesian government to minimize physical contact between doctors and patients in the fight against the Covid-19 pandemic. Various suggestions, directions and decisions from government elements in implementing the policy are aimed at maintaining public health services, without increasing the potential for Covid-19 transmission in health facilities. However, in the midst of optimism for the success of the policy, various policy makers had doubts, especially regarding the readiness of facilities, the ethical dimensions of medical personnel professionalism, and the potential for the emergence of new capitalism in the health sector. Through the stakeholder analysis method of reviewing the existing literature, this study will map and identify the various stakeholders involved in telemedicine implementation, as well as their power, legitimacy and urgency. This identification aims to analyze the relationship between stakeholders and anticipate any counter-productive efforts to the government's strategy in suppressing the spread of the Covid-19 outbreak. The results of this study indicate that there are at least thirty-one stakeholders involved, including the Indonesian Ministry of Health, the Covid-19 Task Force and the Indonesian Medical Council (KKI) as definitive stakeholders, as well as investors, providers of telemedicine platforms and the pharmaceutical industry as dangerous stakeholders.


telemedicine; health services; Covid-19; stakeholders analysis

Full Text:



Apriansyah, T. and Munandar, A. I. (2019) ‘Post Border Control Policy: Stakeholder Analysis Perspective’, Customs Research and Applications Journal, 1(1), pp. 111–125.

Bashshur, R. et al. (2020) ‘Telemedicine and the COVID-19 Pandemic, Lessons For The Future’, Telemedicine and e-Health, 26(5), pp. 571–573.

Beyrer, C. et al. (2015) ‘The Vancouver Consensus: Antiretroviral Medicines, Medical Evidence, And Political Will’, The Lancet. Lancet Publishing Group, pp. 505–507.

Bhaskar, S. et al. (2020) ‘Designing Futuristic Telemedicine Using Artificial Intelligence and Robotics in the COVID-19 Era’, Frontiers in Public Health, 8(November), pp. 1–7.

Bokolo Anthony Jnr (2020) ‘Use of Telemedicine and Virtual Care for Remote Treatment in Response to COVID-19 Pandemic’, Journal of Medical Systems, 44(7), pp. 1–9.

Bragazzi, N. L. et al. (2020) ‘The Role of Hospital and Community Pharmacists in the Management of COVID-19: Towards an Expanded Definition of the Roles, Responsibilities, and Duties of the Pharmacist’, Pharmacy, 8(3), p. 140.

Calton, B., Abedini, N. and Fratkin, M. (2020) ‘Telemedicine in the Time of Coronavirus’, Journal of Pain and Symptom Management, 60(1), pp. e12–e14.

Craig, J. and Patterson, V. (2005) ‘Introduction To The Practice Of Telemedicine’, Journal of Telemedicine and Telecare, 11(1), pp. 3–9.

Dharma, A. A. G. S. S. (2020) ‘Pengaturan Pelayanan Kesehatan yang Dilakukan oleh Dokter Melalui Telemedicine’, Jurnal Magister Hukum Udayana, 9(3), pp. 621–631.

Djoyonegoro, N. (2020) Perang Global Melawan Corona : Perspektif Intelijen. Bogor: Yayasan Insan Waskita Nusantara.

Elliott, T. and Yopes, M. C. (2019) ‘Direct-to-Consumer Telemedicine’, Journal of Allergy and Clinical Immunology: In Practice, 7(8), pp. 2546–2552.

Freeman, R. E. (1984) Strategic management: A stakeholder approach, Strategic Management: A Stakeholder Approach. London: Pitman Publishing Ins.

Gan, W. H., Lim, J. W. and Koh, D. (2020) ‘Preventing Intra-hospital Infection and Transmission of Coronavirus Disease 2019 in Health-care Workers’, Safety and Health at Work, 11(2), pp. 241–243.

Gostin, L. O. and Wiley, L. F. (2020) ‘Governmental Public Health Powers during the COVID-19 Pandemic: Stay-at-home Orders, Business Closures, and Travel Restrictions’, JAMA - Journal of the American Medical Association, 323(21), pp. 2137–2138.

Grigsby, J. and Sanders, J. H. (1998) ‘Telemedicine: Where it is and where it’s going’, Annals of Internal Medicine. American College of Physicians, pp. 123–127.

Hollander, J. E. and Carr, B. G. (2020) ‘Virtually Perfect? Telemedicine for Covid-19’, New England Journal of Medicine, 382(18), pp. 1679–1681.

Jian, D. (2020) Studies on Hospital Management Transformation. Singapore: World Scientific Publishing Co. Pte. Ltd, number 11589.

Kuntardjo, C. (2020) ‘Dimensions of Ethics and Telemedicine in Indonesia: Enough of Permenkes Number 20 Year 2019 As a Frame of Telemedicine Practices in Indonesia?’, Soepra, 6(1), pp. 1–14.

da Luz, P. L. (2019) ‘Telemedicine and the Doctor/Patient Relationship’, Arquivos Brasileiros de Cardiologia. pp. 100–102.

Mahajan, V., Singh, T. and Azad, C. (2020) ‘Using Telemedicine During the COVID-19 Pandemic’, Indian Pediatrics, 57(7), pp. 658–661.

Mitchell, R. K., Agle, B. R. and Wood, D. J. (1997) ‘Toward A Theory Of Stakeholder Identification and Salience: Defining the Principle of Who and What Really Counts’, Academy of Management Review, 22(4), pp. 853–886.

Omboni, S. (2020) ‘Telemedicine during the COVID-19 in Italy: A Missed Opportunity?’, Telemedicine and e-Health, 26(8), pp. 973–975.

Pacis, D. M. M., Subido, E. D. C. and Bugtai, N. T. (2018) ‘Trends In Telemedicine Utilizing Artificial Intelligence’, AIP Conference Proceedings, 1933. doi: 10.1063/1.5023979.

PB IDI (2020) Pedoman Standar Perlindungan Dokter di Era Covid-19. Jakarta: PB Ikatan Dokter Indonesia (PB IDI).

Pinzon, R., Paramitha, D. and Wijaya, V. O. (2020) ‘Acceleration Of Telemedicine Use For Chronic Neurological Disease Patients During Covid-19 Pandemic In Yogyakarta, Indonesia: A Case Series Study’, Kesmas, 15(2), pp. 28–31.

PORI (2020) Kebijakan Pori Teleradioterapi di Masa Pandemik Covid-19. Jakarta: Perhimpunan Dokter Spesialis Onkologi Radiasi Indonesia.

Ran, L. et al. (2020) ‘Risk Factors of Healthcare Workers With Coronavirus Disease 2019: A Retrospective Cohort Study in a Designated Hospital of Wuhan in China’, Clinical Infectious Diseases, 71(16), pp. 2218–2221.

Royce, T. J., Sanoff, H. K. and Rewari, A. (2020) ‘Telemedicine for Cancer Care in the Time of COVID-19’, JAMA Oncology. American Medical Association, pp. 1698–1699.

Santosa (2020) ‘Analisis Dampak Pandemi Covid 19 Terhadap Perekonomian Lokal dari Sudut Pandang Jenis Pekerjaan dan Pendapatan Terhadap Tingkat Daya Beli Masyarakat di Jawa Tengah’, PREPOTIF : Jurnal Kesehatan Masyarakat, 4(2), pp. 253–267.

Sianipar, B. H. (2015) ‘Kebijakan Pengembangan Tele-Medisin di Indonesia’, Kajian Kebijakan dan Hukum Kedirgantaraan, 1(1), pp. 42–62.

Sohrabi, C. et al. (2020) ‘World Health Organization Declares Global Emergency: A Review Of The 2019 Novel Coronavirus (COVID-19)’, International Journal of Surgery. Elsevier Ltd, pp. 71–76.

Stein, R. A. (2015) ‘Political Will And International Collaborative Frameworks In Infectious Diseases’, International Journal of Clinical Practice, 69(1), pp. 41–48.

Usman, U. (2016) ‘Mencari Aktor Utama Dalam Proses Pembuatan Kebijakan Agama (Tinjauan Buku)’, Jurnal Masyarakat dan Budaya, 18(1), pp. 147–155.

Utoyo, B. (2017) ‘Analisis Kebijakan Prinsip Governance dan Aktor Melalui Analytical Hierarchy Process (AHP) dalam Perencanaan Kota’, Jurnal Spirit Publik, 12(1), pp. 45–56.

Waller, M. and Stotler, C. (2018) ‘Telemedicine: a Primer’, Current Allergy and Asthma Reports, 18(10), pp. 1–9.

Wiweko, B., Zesario, A. and Agung, P. G. (2016) ‘Overview The Development Of Tele Health And Mobile Health Application In Indonesia’, ICACSIS, pp. 9–14.

World Health Organization (2010) TELEMEDICINE : Opportunities and developments in Member States. Switzerland: WHO Press.



  • There are currently no refbacks.

Copyright (c) 2021 Andhi Bahtiar, Adis Imam Munandar

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

ISSN 2623-1581(Online) and ISSN 2623- 1573 (Print)
Editorial Address : 
Departement of Public Health
Faculty of Health Sciences University of Pahlawan Tuanku Tambusai
Jalan Tuanku Tambusai 23 Bangkinang, Kampar, Riau, Indonesia Pos Code 28411 Telp. 0762 21677
Contact Us : 0822 6840 410 (dita)
085271651482 (Lira)
Email :